Long-term follow-up on Cushing disease patient after transsphenoidal surgery

Cushing disease is caused by excessive adrenocorticotropic hormone (ACTH) production by the pituitary adenoma. Transsphenoidal surgery is its first-line treatment. The incidence of Cushing disease in children and adolescents is so rare that long-term prognoses have yet to be made in most cases. We f...

Full description

Bibliographic Details
Main Authors: Insook Jeong, Moonyeon Oh, Ja Hye Kim, Ja Hyang Cho, Jin-Ho Choi, Han-Wook Yoo
Format: Article
Language:English
Published: Korean Society of Pediatric Endocrinology 2014-09-01
Series:Annals of Pediatric Endocrinology & Metabolism
Subjects:
Online Access:http://e-apem.org/upload/pdf/apem-19-164.pdf
_version_ 1828544407056416768
author Insook Jeong
Moonyeon Oh
Ja Hye Kim
Ja Hyang Cho
Jin-Ho Choi
Han-Wook Yoo
author_facet Insook Jeong
Moonyeon Oh
Ja Hye Kim
Ja Hyang Cho
Jin-Ho Choi
Han-Wook Yoo
author_sort Insook Jeong
collection DOAJ
description Cushing disease is caused by excessive adrenocorticotropic hormone (ACTH) production by the pituitary adenoma. Transsphenoidal surgery is its first-line treatment. The incidence of Cushing disease in children and adolescents is so rare that long-term prognoses have yet to be made in most cases. We followed-up on a 16-year-old male Cushing disease patient who presented with rapid weight gain and growth retardation. The laboratory findings showed increased 24-hour urine free cortisol and lack of overnight cortisol suppression by low-dose dexamethasone test. The serum cortisol and 24-hour urine free cortisol, by high-dose dexamethasone test, also showed a lack of suppression, and a bilateral inferior petrosal sinus sampling suggested lateralization of ACTH secretion from the right-side pituitary gland. However, after a right hemihypophysectomy by the transsphenoidal approach, the 24-hour urine free cortisol levels were persistently high. Thus the patient underwent a total hypophysectomy, since which time he has been treated with hydrocortisone, levothyroxine, recombinant human growth hormone, and testosterone enanthate. Intravenous bisphosphonate for osteoporosis had been administered for three years. At his current age of 26 years, his final height had attained the target level range; his bone mineral density was normal, and his pubic hair was Tanner stage 4. This report describes the long-term treatment course of a Cushing disease patient according to growth profile, pubertal status, and responses to hormone replacement therapy. The clinical results serve to emphasize the importance of growth optimization, puberty, and bone health in the treatment management of Cushing disease patients who have undergone transsphenoidal surgery.
first_indexed 2024-12-12T02:30:09Z
format Article
id doaj.art-cc1df30bf8fa4543b59c897fa15988a5
institution Directory Open Access Journal
issn 2287-1012
2287-1292
language English
last_indexed 2024-12-12T02:30:09Z
publishDate 2014-09-01
publisher Korean Society of Pediatric Endocrinology
record_format Article
series Annals of Pediatric Endocrinology & Metabolism
spelling doaj.art-cc1df30bf8fa4543b59c897fa15988a52022-12-22T00:41:27ZengKorean Society of Pediatric EndocrinologyAnnals of Pediatric Endocrinology & Metabolism2287-10122287-12922014-09-0119316416810.6065/apem.2014.19.3.164546Long-term follow-up on Cushing disease patient after transsphenoidal surgeryInsook Jeong0Moonyeon Oh1Ja Hye Kim2Ja Hyang Cho3Jin-Ho Choi4Han-Wook Yoo5Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.Cushing disease is caused by excessive adrenocorticotropic hormone (ACTH) production by the pituitary adenoma. Transsphenoidal surgery is its first-line treatment. The incidence of Cushing disease in children and adolescents is so rare that long-term prognoses have yet to be made in most cases. We followed-up on a 16-year-old male Cushing disease patient who presented with rapid weight gain and growth retardation. The laboratory findings showed increased 24-hour urine free cortisol and lack of overnight cortisol suppression by low-dose dexamethasone test. The serum cortisol and 24-hour urine free cortisol, by high-dose dexamethasone test, also showed a lack of suppression, and a bilateral inferior petrosal sinus sampling suggested lateralization of ACTH secretion from the right-side pituitary gland. However, after a right hemihypophysectomy by the transsphenoidal approach, the 24-hour urine free cortisol levels were persistently high. Thus the patient underwent a total hypophysectomy, since which time he has been treated with hydrocortisone, levothyroxine, recombinant human growth hormone, and testosterone enanthate. Intravenous bisphosphonate for osteoporosis had been administered for three years. At his current age of 26 years, his final height had attained the target level range; his bone mineral density was normal, and his pubic hair was Tanner stage 4. This report describes the long-term treatment course of a Cushing disease patient according to growth profile, pubertal status, and responses to hormone replacement therapy. The clinical results serve to emphasize the importance of growth optimization, puberty, and bone health in the treatment management of Cushing disease patients who have undergone transsphenoidal surgery.http://e-apem.org/upload/pdf/apem-19-164.pdfPituitary ACTH hypersecretionPetrosal sinus samplingHypopituitarism
spellingShingle Insook Jeong
Moonyeon Oh
Ja Hye Kim
Ja Hyang Cho
Jin-Ho Choi
Han-Wook Yoo
Long-term follow-up on Cushing disease patient after transsphenoidal surgery
Annals of Pediatric Endocrinology & Metabolism
Pituitary ACTH hypersecretion
Petrosal sinus sampling
Hypopituitarism
title Long-term follow-up on Cushing disease patient after transsphenoidal surgery
title_full Long-term follow-up on Cushing disease patient after transsphenoidal surgery
title_fullStr Long-term follow-up on Cushing disease patient after transsphenoidal surgery
title_full_unstemmed Long-term follow-up on Cushing disease patient after transsphenoidal surgery
title_short Long-term follow-up on Cushing disease patient after transsphenoidal surgery
title_sort long term follow up on cushing disease patient after transsphenoidal surgery
topic Pituitary ACTH hypersecretion
Petrosal sinus sampling
Hypopituitarism
url http://e-apem.org/upload/pdf/apem-19-164.pdf
work_keys_str_mv AT insookjeong longtermfollowuponcushingdiseasepatientaftertranssphenoidalsurgery
AT moonyeonoh longtermfollowuponcushingdiseasepatientaftertranssphenoidalsurgery
AT jahyekim longtermfollowuponcushingdiseasepatientaftertranssphenoidalsurgery
AT jahyangcho longtermfollowuponcushingdiseasepatientaftertranssphenoidalsurgery
AT jinhochoi longtermfollowuponcushingdiseasepatientaftertranssphenoidalsurgery
AT hanwookyoo longtermfollowuponcushingdiseasepatientaftertranssphenoidalsurgery